Eyebright Medical Technology Beijing Co Ltd (688050) - Total Liabilities
Based on the latest financial reports, Eyebright Medical Technology Beijing Co Ltd (688050) has total liabilities worth CN¥894.96 Million CNY (≈ $130.96 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Eyebright Medical Technology Beijing Co (688050) cash flow conversion to assess how effectively this company generates cash.
Eyebright Medical Technology Beijing Co Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Eyebright Medical Technology Beijing Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Eyebright Medical Technology Beijing Co liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Eyebright Medical Technology Beijing Co Ltd Competitors by Total Liabilities
The table below lists competitors of Eyebright Medical Technology Beijing Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangsu Dagang Co Ltd
SHE:002077
|
China | CN¥745.72 Million |
|
Concentrix Corporation
NASDAQ:CNXC
|
USA | $7.89 Billion |
|
Taiwan Fertilizer Co Ltd
TW:1722
|
Taiwan | NT$27.25 Billion |
|
Telecom Argentina S.A
F:TEO
|
Germany | €9.09 Trillion |
|
Jiangsu Rongtai Industry Co. Ltd.
SHG:605133
|
China | CN¥2.76 Billion |
|
Huafa Industrial Co Ltd Zhuhai
SHG:600325
|
China | CN¥279.76 Billion |
|
Uwc Bhd
KLSE:5292
|
Malaysia | RM149.28 Million |
|
FLEX LNG Ltd
OL:FLNG
|
Norway | Nkr1.87 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Eyebright Medical Technology Beijing Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688050 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eyebright Medical Technology Beijing Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eyebright Medical Technology Beijing Co Ltd (2016–2024)
The table below shows the annual total liabilities of Eyebright Medical Technology Beijing Co Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥862.71 Million ≈ $126.24 Million |
+22.22% |
| 2023-12-31 | CN¥705.85 Million ≈ $103.29 Million |
+117.65% |
| 2022-12-31 | CN¥324.30 Million ≈ $47.46 Million |
+5.48% |
| 2021-12-31 | CN¥307.46 Million ≈ $44.99 Million |
+238.26% |
| 2020-12-31 | CN¥90.89 Million ≈ $13.30 Million |
+137.60% |
| 2019-12-31 | CN¥38.26 Million ≈ $5.60 Million |
+17.40% |
| 2018-12-31 | CN¥32.59 Million ≈ $4.77 Million |
-58.02% |
| 2017-12-31 | CN¥77.62 Million ≈ $11.36 Million |
+69.20% |
| 2016-12-31 | CN¥45.88 Million ≈ $6.71 Million |
-- |
About Eyebright Medical Technology Beijing Co Ltd
Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company offers intraocular, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also provides solutions for opht… Read more